| 3/29/2024 | 29419090 | "PH.RAW MATERIAL" ENROFLOXACIN HCL
BATCH NO. DK05-2401104 MFT DT.10.01.2024 EXP DT.09.01.2027
ADC NO.E-8613088591694 DT : 12.03.2024 | XXXXXXXXXX | 1000 | KG | 22124.884892 | China | KAPW |
| 3/29/2024 | 29419090 | "PH.RAW MATERIAL" ENROFLOXACIN HCL
BATCH NO. DK05-2401104 MFT DT.10.01.2024 EXP DT.09.01.2027
ADC NO.E-8613088591694 DT : 12.03.2024 | XXXXXXXXXX | 1000 | KG | 22124.884892 | China | KAPW |
| 3/29/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL CEFEPIME HCL WITH L-ARGININE (BATCH NO: MFG: & EXP: AS PER FORM 7) | XXXXXXXXXX | 30 | KG | 5518.446043 | China | KPAF |
| 3/29/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL CEFEPIME HCL WITH L-ARGININE (BATCH NO: MFG: & EXP: AS PER FORM 7) | XXXXXXXXXX | 30 | KG | 5518.446043 | China | KPAF |
| 3/26/2024 | 29419090 | FUSIDIC ACID EP 10.4 (MICRONISED) AS PER INV / PL (BANK CONTRACT # HMBC/99/072/821 DATE : 01-02-2024) | XXXXXXXXXX | 25 | KG | 11241.272923 | China | KPAF |
| 3/26/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL LINCOMYCIN HCL EP (BATCH NO.231237055 & 231237058 MFG:12.2024 EXP:12.2026) | XXXXXXXXXX | 1000 | KG | 33212.855088 | China | KAPW |
| 3/26/2024 | 29419090 | FUSIDIC ACID EP 10.4 (MICRONISED) AS PER INV / PL (BANK CONTRACT # HMBC/99/072/821 DATE : 01-02-2024) | XXXXXXXXXX | 25 | KG | 11241.272923 | China | KPAF |
| 3/26/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL LINCOMYCIN HCL EP (BATCH NO.231237055 & 231237058 MFG:12.2024 EXP:12.2026) | XXXXXXXXXX | 1000 | KG | 33212.855088 | China | KAPW |
| 3/25/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY DOXYCYCLINE HCL BATCH NO.: 711-2312071 MFG. DATE: DEC.30, 2023
RETEST DATE: DEC.29, 2025 | XXXXXXXXXX | 300 | KG | 12733.267469 | China | KAPW |
| 3/25/2024 | 29419090 | PHARMACEUTICAL RAW MATERIAL
RIFAMPICIN BP/USP/EP
NET WT: 2500 KGS | XXXXXXXXXX | 2500 | KG | 417748.765942 | China | KAPW |